148 related articles for article (PubMed ID: 37640964)
1. FOXO1-regulated lncRNA CYP1B1-AS1 suppresses breast cancer cell proliferation by inhibiting neddylation.
Tang L; Wei D; Xu X; Mo D; Cheng D; Yan F
Breast Cancer Res Treat; 2023 Nov; 202(2):397-408. PubMed ID: 37640964
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
[TBL] [Abstract][Full Text] [Related]
3. LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6.
Zhang X; Zhao X; Chang L; Liu F; Li C; Ge P
Breast Cancer; 2022 Sep; 29(5):908-920. PubMed ID: 35678943
[TBL] [Abstract][Full Text] [Related]
4. CYP1B1-AS1 Delays the Malignant Progression of Colorectal Cancer by Binding with NOP58.
Wu Z; Cheng F; Yuan L; Li X; Li Z; Huang Z; Mao S; Chen X; Wang J; Lai B; Shen W
Dig Dis Sci; 2024 Feb; 69(2):437-452. PubMed ID: 38087130
[TBL] [Abstract][Full Text] [Related]
5. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
6. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
Feng Z; Chen R; Huang N; Luo C
Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
[TBL] [Abstract][Full Text] [Related]
7. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
[TBL] [Abstract][Full Text] [Related]
8. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
Hussain SA; Venkatesh T
Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
[TBL] [Abstract][Full Text] [Related]
9. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway.
Zhang M; Wang Y; Jiang L; Song X; Zheng A; Gao H; Wei M; Zhao L
J Exp Clin Cancer Res; 2021 Jan; 40(1):41. PubMed ID: 33494806
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
11. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
Zhou Y; Feng D; Gu X; Gao A; Liu Y
Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
[TBL] [Abstract][Full Text] [Related]
12. LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2,3 sialylation via PI3K/Akt signaling.
Hu J; Shan Y; Ma J; Pan Y; Zhou H; Jiang L; Jia L
Int J Cancer; 2019 Jul; 145(2):450-460. PubMed ID: 30613961
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
Yang J; Wu W; Wu M; Ding J
In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
16. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
18. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
Song W; Zhang J; Xia Q; Sun M
Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
[No Abstract] [Full Text] [Related]
19. LncRNA AFAP1-AS1 Knockdown Represses Cell Proliferation, Migration, and Induced Apoptosis in Breast Cancer by Downregulating
Cai B; Wang X; Bu Q; Li P; Xue Q; Zhang J; Ding P; Sun D
Cancer Biother Radiopharm; 2022 Oct; 37(8):662-672. PubMed ID: 32955920
[No Abstract] [Full Text] [Related]
20. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway.
Zhao X; Cheng Z; Wang J
Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
